SlideShare a Scribd company logo
1 of 63
Behandling av undernäring ger bättre kliniskt förlopp för patienten. 2008 Lund Department of Human Nutrition Rigshospitalet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],University of Copenhagen Jens Kondrup
loBMI Stratton RJ, Green CJ, Elia M. Disease-related malnutrition. CABI Publishing 2003
Wt loss
E intake
Prevalence of undernutrition Stratton RJ, Green CJ, Elia M. Disease-related malnutrition  CABI Publishing 2003 10 30 % of these undernourished 995 150 Prevalence (per 100.000) 10 100 % of these diseased 99.5 0.5 % of population Community Hospital
Europe 1 OOPS! 26 departments from 12 countries  Interested, but limited experience with nutrition support. Sponsored by Fresenius-Kabi. 49 560 216 306 48 22 296 59 131 83 88 187 856 388 479 21 182 50 52 68 273 276 151 162 207 60
% at risk according to NRS-2002 Sorensen et al. Clin Nutr   2008; 27: 340-9 32 543 Gastroenterology 94 309 ICU 28 338 Oncology 5051 209 1783 1715 N 33 52 33 19 % At-risk Total Geriatrics Internal medicine Surgery
Complications Sorensen et al. Clin Nutr   2008; 27: 340-9 100   (1647) 14 (234) 16 (270) 69 (1143) At-risk * P<0.001 100   (3404) 5   (165) 6 (218) 89   (3021) Not at-risk Total Infectious Complication Non-infectious Complication No Complication   At risk according to NRS-2002 Percent of patients with non-infectious or infectious complications (N) Cancer Age Region (Western Europe, Eastern Europe, Middle East) Speciality (geriatry, gastroenterology, oncology, internal medicine, surgical, ICU) Diagnoses (19 most frequent) Comorbidity Surgery Complications were independenly  associated with NRS-2002 components (nutritional status and severity of disease), also when adjusted for:
Type of complications Sorensen et al. EuroOOPS: an international, multicentre study of nutritional risk screening  and clinical outcome in 5.000 patients.  Clin Nutr  27 340-9, 2008 Primary disease determines the type of complication - malnutrition makes it happen
LOS, all   Sorensen et al. Clin Nutr   2008; 27: 340-9
Length of stay Sorensen et al. Clin Nutr   2008; 27: 340-9 12.9    0.4   (189) 11.2    0.4   (219) 8.9    0.2  (1055) At-risk Not At-risk No Complication  versus  all other groups: P<0.0001 for each   11.0    0.5  (127) 10.9    0.4  (199) 6.9    0.1   (2881) Not at-risk Infectious Complication Total Non-infectious Complication No Complication   At risk according to NRS-2002: LOS (mean    SEM) in different categories (N) Cancer Age Region (Western Europe, Eastern Europe, Middle East) Death. Speciality (geriatry, gastroenterology, oncology, internal medicine, surgical, ICU) Diagnoses (19 most frequent) Comorbidity Surgery LOS was independenly  associated with NRS-2002 components (nutritional status and severity of disease), also when adjusted for:
Length of stay; survival Sorensen et al. Clin Nutr   2008; 27: 340-9
Odds for discharge < 28 days Sorensen et al. Clin Nutr   2008; 27: 340-9 Cox regression analysis N = 5046; LOS    28 (N=379) are right censored   <0.0001   0.78   Co-morbidity   <0.0001   0.55   Complication  <0.0001   0.74   Cancer   0.008   1.09   Surgery   0.003   1.09   Sex, male  versus  female   <0.0001 0.76 At-risk P OR
Prevalence of malnutrition in Denmark 36 Orthoped surgery (249)  57 Gastro surgery (148) 42 Internal medicine (238) % at-risk NRS-2002 Speciality (N) A random selection of 5 departments for each of 3 specialities: internal medicine, gastro-surgery and orthopedic surgery in hospitals >200 beds. Result:15 departments in 12 out of 33 hospitals.  Rasmussen et al. Clin Nutr 2004;23:1009-15 .
Prevalence: Care 14 (33:8) 1)   Plan (req, food type, monitor) 1)   Related to recent weight loss and severity of disease, but not to BMI or recent intake 20 (33:10) Recent dietary intake  12 (19:7) Recent weight loss 64 (similar) Weight % (at-risk:not at risk) Information in records Nutritional care Rasmussen et al. Clin Nutr 2004;23:1009-15.
Behandling av undernäring ger bättre kliniskt förlopp för patienten. 2008 Lund Department of Human Nutrition Rigshospitalet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],University of Copenhagen Jens Kondrup
Evidence is here! Meta-analysis of a large number of trials shows that nutritional support improves clinical outcome Stratton RJ, Green CJ, Elia M.  Disease-related malnutrition:  an evidence-based approach.  CABI Publishing 2003
RCT: Complications % mortality Stratton RJ, Green CJ, Elia M. Disease-related malnutrition. CABI Publishing 2003 24% vs. 44% 1) Infections 2) 17 % vs. 24% 1) Mortality 1)  P <0.001;  2) 10 RCTs only Meta-analysis of  27 RCTs with 1710 patients (complications) and  30 RCTs with 3250 patients (mortality). Neurology, GI disease, liver disease, malignant disease, elderly, abdominal surgery, orthopaedic surgery, critical illness/injury, burns. Hospital or community Oral supplements or tube feeding 28% vs. 46% 1) Complications
Meta-analysis: Surgery Stratton RJ, Green CJ, Elia M. Disease-related malnutrition 2003
Meta-analysis: Internal medicin Stratton RJ, Green CJ, Elia M. Disease-related malnutrition 2003
Clinical effect: Gastro-intestinal surgery References in Kondrup et al. Clin Nutr 2003; 22:  321-336 infection/ON (82) infection/ON (79) infection/EN (20) infection/EN (37) infection/EN (83) infection/EN (84) infection/PN (1) infection/PN (19) infection/PN (38) infection/PN/EN (80) infection/PN (123) complications/ PN (77) complications/PN (78) complications/PN (87) complications/PN (124) LOS/EN (86) LOS/PN (21) survival/PN (43) survival/PN (125)
Clinical effect: References in Kondrup et al. Clin Nutr 2003; 22:  321-336 tolerance/ON (2) tolerance/PN (39) tolerance/PN (40) tolerance/ON (41) QoL/EN (35) survival/PN (44) survival/PN (91) Cancer   Clin Index/PN (36) encephalopathy/EN (42) infection/EN (81) LOS/PN (88) survival/ON (93)   Cirrhosis LOS/ON (3) LOS/ON (4) survival/EN (5) Femoral fracture infection/EN (18) LOS/EN (29) survival/PN (30)   Trauma ADL/ON (34) ADL/ON (85) survival/ON (45) Geriatry survival/PN (89) survival/PN (90) Acute Renal Failure infection/burns/EN (28) survival/BMT/PN (31) survival/stroke/ON (92) Misc.
Behandling av undernäring ger bättre kliniskt förlopp för patienten. 2008 Lund Department of Human Nutrition Rigshospitalet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],University of Copenhagen Jens Kondrup
Impact of malnutrition on healthcare costs The pooled results from the analysis of all the hospital-based studies indicated a mean net cost saving from the use of oral nutritional supplements of £849 per patient based on bed-day costs and £298 per patient using complication costs. Russell C, Clinical Nutrition Supplements   2007;   2: 25–32 Elia M, Stratton RJ, Russell C, Green CJ, Pang F. The Cost of disease–related malnutrition in the UK. BAPEN 2005 The total direct costs of disease-related malnutrition represent approximately 10% of the total expenditure on health in the UK.  7.3 £ million is two fold greater than the reported costs of managing obesity and its consequences in the UK
UK Costs applied to Euro-OOPS. LOS + Complications Calculated from Cost of LOS (£ 258/day) + Cost of  Complication (£ 1500) with extra LOS subtracted ((LOS compl-LOS no compl) x £ 258) Based on Elia M, Stratton RJ, Russell C, Green CJ, Pang F. The Cost of disease–related malnutrition in the UK. BAPEN 2005 1.6 0.3 1.3 408 Mal, compl 2.4 0.9 5.1 10 6 £ LOS 0.2 10 6 £ Compl >   LOS 1055 326 2881 N Total Mal, no compl Well, compl Well, no compl Group 5.1 10.2 2.4 1.1 10 6 £ Total
UK Costs applied to Euro-OOPS. Additional cost of malnutrition: (Cost of mal) – (# of mal x cost of average well    complications, £ 1929) Based on Elia M, Stratton RJ, Russell C, Green CJ, Pang F. The Cost of disease–related malnutrition in the UK. BAPEN 2005 11% Mal in % of total (1.1 x 100/10.2) 10.2 Total, £ million (2.4 +1.6) – (1,463 x 1,929) = 1.1 £ million
UK Costs applied to Euro-OOPS. Additional cost of treated malnutrition: (Cost of mal) – (# of mal x cost of average well    complications, £ 1929) Elia M, Stratton RJ, Russell C, Green CJ, Pang F.The Cost of disease–related malnutrition in the UK. BAPEN 2005 0.7 Cost of treated mal (0.4 + 0.3), £ million 0.3 Cost of treatment (# mal x LOS x £ 24.6), £ million 6% Treated mal, % of total (0.7 x 100/10.2) 10.2 Total, £ million (2.4 +0.7) – (1,463 x 1,929) = 0.4 £ million versus 1.1 in untreated
Results applied to DK health care (in £) 140 £ million = 1.3 milliarder DKK 140 Saving, £ million 7. 287 Mal, 11% of 2., £ million 5. 146 Treated mal, 6% of 2., £ million 6. 8. 4. 3. 2. 1. 5,442 Total costs for in-patients, £ million 6.0 Saving, % of Total DRG (=7./2.) 392 Av bed day cost DRG, £ (= 2./3.) 6.5 Bed days per year, million 2,547  Total DRG costs, £ million Item
Behandling av undernäring ger bättre kliniskt förlopp för patienten. 2008 Lund Department of Human Nutrition Rigshospitalet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],University of Copenhagen Jens Kondrup
European Council’s Committee of Ministers Resolution November 12th 2003 on Food in Hospitals:   https://wcm.coe.int/ViewDoc.jsp?id=85747&Lang=en ,[object Object],[object Object],[object Object],[object Object]
Council of Europe’s Committee of Ministers : Resolution November 12th 2003 ,[object Object],[object Object],[object Object]
Appendix:  The level of government/health authority Editorial Clin Nutr 2004; 23:135-137 ,[object Object],[object Object],[object Object],[object Object]
Appendix:  The level of government/health authority Editorial Clin Nutr 2004; 23:135-137 These key recommendations will help the level of government/health authority to: 1) evaluate the adequacy of nutrition activities in individual hospitals 2) evaluate unfortunate individual cases.
Appendix: T he level of hospital/department/patient Editorial Clin Nutr 2004; 23:135-137 ,[object Object],[object Object],[object Object],[object Object]
Appendix: T he level of hospital/department/patient ,[object Object],[object Object],Editorial Clin Nutr 2004; 23:135-137
EU… Europaparlamentet vedtog den 25.  September 2008 ændringer til EU kommissionens ’White paper on nutrition, overweight and obesity-related health issues’ fra Juni 2007   Malnutrition is a heavy burden both for individual wellbeing and for society, particularly the health care system, and it results in increased mortality, longer hospital stays, greater complications and reduced quality of life for patients; extra days in hospital and treatment of complications due to malnutrition cost billions of euros in public funding every year.   Urges the Commission to take a more holistic approach to nutrition and make malnutrition, alongside obesity, a key priority in the fields of nutrition and health, incorporating it wherever possible into EU-funded research initiatives and EU-level partnerships.
Governmentally approved national guidelines in… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Behandling av undernäring ger bättre kliniskt förlopp för patienten. 2008 Lund Department of Human Nutrition Rigshospitalet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],University of Copenhagen Jens Kondrup
Institut for Kvalitet og Akkreditering i Sundhedsvæsenet   www.kvalitetsinstitut.dk
De danske sygehuse indfører modellen 15. august 2009.   ,[object Object],[object Object],[object Object]
STANDARD 2.14.1 ERNÆRINGSSCREENING: > Indlagte patienters ernæringsmæssige risiko vurderes<   F ormål: At identificere patienter i særlig risiko for komplikationer og forlænget rekonvalescens på grund af uhensigtsmæssig ernæring ,[object Object],[object Object],[object Object],[object Object],[object Object]
Standard 2.14.2 ERNÆRINGSPLAN OG OPFØLGNING: > Indlagte patienter i ernæringsmæssig risiko får en tilpasset ernæring< F ormål:  At forebygge komplikationer, fremme helbredelse og undgå forlænget rekonvalescens på grund af uhensigtsmæssig ernæring. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Behandling av undernäring ger bättre kliniskt förlopp för patienten. 2008 Lund Department of Human Nutrition Rigshospitalet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],University of Copenhagen Jens Kondrup
Key question: Nutritional support was effective in the RCTs –  but how were the patients actually selected? Do the patients selected for these studies have a common  denominator for risk of nutrition-related complications (= nutritional risk) ? To implement the evidence: develop a screening tool based on evidence that outcome will change, i.e. the available RCTs Other specialities? Fraction of patients   etc Speciality 4 Speciality 3 Speciality 2 Speciality 1
 
Concept Nutritional risk = risk of complications due to nutritional impairment
Components in Screening by NRS-2002 – ESPEN guideline Impaired nutritional status BMI (   present condition) Recent weight loss (   past tendency) Recent dietary intake (   future tendency) Nutritional requirements    Severity of disease  E.g. protein requirements in various disease  states (stress metabolism) www.espen.org    education; Kondrup et al. Clin Nutr 2003; 22:  321-336  + 415-421
NRS-2002 _DK www.espen.org    education; Kondrup et al. Clin Nutr 2003; 22:  321-336  + 415-421 Hvis alder    70: læg 1 til Total.  Ved Total    3: start ernæringsterapi Score  = Total: Score  + Kranietraumer, forbrænding > 50% S være infektioner (sepsis), intensiv ptt . Svær = 3 Vægttab > 5% på 1 måned/15% på 3 måneder 1 eller BMI    18,5 og påvirket almentilstand eller Kostindtagelse 0-25%    1 uge   Svær = 3 Store abdominalkirurgiske indgreb (colektomi, gastrektomi, hepatektomi) Postoperativ ATIN, apopleksi Svær pneumoni Moderat = 2 Vægttab > 5% på 1 1/2  måned eller BMI 18,5-20,5 og påvirket almentilstand eller Kostindtagelse 25-50%    1 uge   Moderat = 2 Collum femoris fraktur Kronisk prægede ptt., særligt ved akutte komplikationer: levercirrhose, KOL Kronisk prægede ptt. med nyreinsufficiens,  IDDM eller cancer   Let = 1 Vægttab > 5% på 3 måneder  eller Kostindtagelse 50-75%    1 uge   Let = 1 Sværhedsgrad af sygdom Underernæring
all
ON Kondrup et al. Clin Nutr 2003; 22: 321-336
EN Kondrup et al. Clin Nutr 2003; 22: 321-336
PN Kondrup et al. Clin Nutr 2003; 22: 321-336
UPS_RCT_method ,[object Object],[object Object],[object Object],[object Object],Johansen N et al. Clin Nutr 2004; 23:539-550
Intake UPS    This is the solution  
RCT with 212 at-risk patients (NRS-2002) randomized to departments’ routine or daily follow-up by team of nurse and dietitian. Length of Stay Johansen N et al. Clin Nutr 2004; 23:539-550 1)  Team  versus  Control: P = 0.028; ANOVA   17    2 1)   18   22    2   14   Complications   9    1   50   9    1   69   No complications   Mean    SEM N Mean    SEM N Team Control
Behandling av undernäring ger bättre kliniskt förlopp för patienten. 2008 Lund Department of Human Nutrition Rigshospitalet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],University of Copenhagen Jens Kondrup
ESPEN guideline: screening linked to action ESPEN Guidelines for Nutrition Screening 2002. Clin Nutr 2003;22(4):415-421. 1. Screening 2. Nutrition Plan 3. Monitoring 4. Communication 5. Audit
Nutrition treatment: a structured process ESPEN Guidelines for Nutrition Screening 2002. Clin Nutr 2003;22(4):415-421.
Context of the structured process Kondrup Clin Nutr 2001; 20(suppl 2): 153-160, b ased on BAPEN report 1999: Hospital Food  as  Treatment
Copenhagen audit March 2006 Accreditation 2002 & 2005
Reliability of audit results in Copenhagen 480 patients in 24 departments in 5 hospitals Holm et al. ESPEN Congress 2006: Abstract # P 0281 91%   3) 74% 106/143 Dietary recording Correct, % Done, %  n/N Activity Most frequent causes of errors: 1)  Undiscovered weight loss 2)  Undiscovered weight loss/wrong category of severity of disease 3)  Erroneus calculation of requirements   89%  2) 98% 220/224 Final screening 85%  1) 78% 374/480 Initial screening
Causes of inadequate intake 111 of 246 at-risk patients had an intake <75% of requirement. The nurses gave max 1 answer in each of 5 categories: Patient, Nurse, Food, System, Other. An average of 3 reasons per patient. 83 different combinations. 74 patients had an individual combination. The combinations shared by    3 patients are shown here.   Holm et al. ESPEN Congress 2006: Abstract # P 0281
Behandling av undernäring ger bättre kliniskt förlopp för patienten. 2008 Lund Department of Human Nutrition Rigshospitalet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],University of Copenhagen Jens Kondrup

More Related Content

What's hot

(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24Hyung Jin Choi
 
유전체의학과 미래의학 1 유전체의학_공개용
유전체의학과 미래의학 1 유전체의학_공개용유전체의학과 미래의학 1 유전체의학_공개용
유전체의학과 미래의학 1 유전체의학_공개용Hyung Jin Choi
 
의료 빅데이터 - 개념 입문과 임상의사가 할 수 있는 일
의료 빅데이터 - 개념 입문과 임상의사가 할 수 있는 일의료 빅데이터 - 개념 입문과 임상의사가 할 수 있는 일
의료 빅데이터 - 개념 입문과 임상의사가 할 수 있는 일Hyung Jin Choi
 
Radioisotopes in the management of bone metastases
Radioisotopes in the management of bone metastasesRadioisotopes in the management of bone metastases
Radioisotopes in the management of bone metastasesSneha George
 
Prognosti Check Phase Angle Bibliography
Prognosti Check Phase Angle BibliographyPrognosti Check Phase Angle Bibliography
Prognosti Check Phase Angle BibliographyIPGDx LLC
 
헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가? Hyung Jin Choi
 
Metastatic Spine Lesions
Metastatic Spine LesionsMetastatic Spine Lesions
Metastatic Spine LesionsAde Wijaya
 
Denosumab vs bisfosfonato en metástasis óseas
Denosumab vs bisfosfonato en metástasis óseasDenosumab vs bisfosfonato en metástasis óseas
Denosumab vs bisfosfonato en metástasis óseasMauricio Lema
 
MPH Thesis Tesfaye Kasaye
MPH Thesis Tesfaye KasayeMPH Thesis Tesfaye Kasaye
MPH Thesis Tesfaye KasayeTesfaye Abrhame
 
Yokota-2017-Effect of Capacitive and Resistive.pdf
Yokota-2017-Effect of Capacitive and Resistive.pdfYokota-2017-Effect of Capacitive and Resistive.pdf
Yokota-2017-Effect of Capacitive and Resistive.pdfCongestionPelvienne
 

What's hot (19)

Research Presentation
Research PresentationResearch Presentation
Research Presentation
 
Metastases of spine
Metastases of spineMetastases of spine
Metastases of spine
 
Astro bone mets
Astro bone metsAstro bone mets
Astro bone mets
 
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24(서울의대 공유용) 빅데이터 분석  유전체 정보와 개인라이프로그 정보 활용-2015_11_24
(서울의대 공유용) 빅데이터 분석 유전체 정보와 개인라이프로그 정보 활용-2015_11_24
 
유전체의학과 미래의학 1 유전체의학_공개용
유전체의학과 미래의학 1 유전체의학_공개용유전체의학과 미래의학 1 유전체의학_공개용
유전체의학과 미래의학 1 유전체의학_공개용
 
의료 빅데이터 - 개념 입문과 임상의사가 할 수 있는 일
의료 빅데이터 - 개념 입문과 임상의사가 할 수 있는 일의료 빅데이터 - 개념 입문과 임상의사가 할 수 있는 일
의료 빅데이터 - 개념 입문과 임상의사가 할 수 있는 일
 
IWO bijeenkomst - 14 november - Dr. F. Malgo
IWO bijeenkomst - 14 november - Dr. F. MalgoIWO bijeenkomst - 14 november - Dr. F. Malgo
IWO bijeenkomst - 14 november - Dr. F. Malgo
 
Radioisotopes in the management of bone metastases
Radioisotopes in the management of bone metastasesRadioisotopes in the management of bone metastases
Radioisotopes in the management of bone metastases
 
Prognosti Check Phase Angle Bibliography
Prognosti Check Phase Angle BibliographyPrognosti Check Phase Angle Bibliography
Prognosti Check Phase Angle Bibliography
 
헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?헬스케어 빅데이터로 무엇을 할 수 있는가?
헬스케어 빅데이터로 무엇을 할 수 있는가?
 
IWO bijeenkomst - 14 april - Prof. Dr. M.C. Zillikens
IWO bijeenkomst - 14 april - Prof. Dr. M.C. ZillikensIWO bijeenkomst - 14 april - Prof. Dr. M.C. Zillikens
IWO bijeenkomst - 14 april - Prof. Dr. M.C. Zillikens
 
Metastatic Spine Lesions
Metastatic Spine LesionsMetastatic Spine Lesions
Metastatic Spine Lesions
 
EUS-CPN
EUS-CPNEUS-CPN
EUS-CPN
 
changepatella paper
changepatella paperchangepatella paper
changepatella paper
 
Denosumab vs bisfosfonato en metástasis óseas
Denosumab vs bisfosfonato en metástasis óseasDenosumab vs bisfosfonato en metástasis óseas
Denosumab vs bisfosfonato en metástasis óseas
 
Bone Metastases
Bone MetastasesBone Metastases
Bone Metastases
 
5.17.11.stones
5.17.11.stones5.17.11.stones
5.17.11.stones
 
MPH Thesis Tesfaye Kasaye
MPH Thesis Tesfaye KasayeMPH Thesis Tesfaye Kasaye
MPH Thesis Tesfaye Kasaye
 
Yokota-2017-Effect of Capacitive and Resistive.pdf
Yokota-2017-Effect of Capacitive and Resistive.pdfYokota-2017-Effect of Capacitive and Resistive.pdf
Yokota-2017-Effect of Capacitive and Resistive.pdf
 

Viewers also liked

Aarbog 09 1979_forsknings_og_litteraturoversigt
Aarbog 09 1979_forsknings_og_litteraturoversigtAarbog 09 1979_forsknings_og_litteraturoversigt
Aarbog 09 1979_forsknings_og_litteraturoversigtSFAH
 
ABC Breakfast Club m. Abena: 40% færre restordre
ABC Breakfast Club m. Abena: 40% færre restordreABC Breakfast Club m. Abena: 40% færre restordre
ABC Breakfast Club m. Abena: 40% færre restordreABC Softwork
 
You gov bankundersøgelse_finansagenda2014_final
You gov bankundersøgelse_finansagenda2014_finalYou gov bankundersøgelse_finansagenda2014_final
You gov bankundersøgelse_finansagenda2014_finalKommunikationsforening
 
Community development and networks
Community development and networksCommunity development and networks
Community development and networksLeif Rasmussen
 
Programma di sala novembre 2011
Programma di sala novembre 2011Programma di sala novembre 2011
Programma di sala novembre 2011Verdipordenone
 
Time Management Energistyrelsen
Time Management EnergistyrelsenTime Management Energistyrelsen
Time Management EnergistyrelsenRené Claus Larsen
 
Ecosystems presentation
Ecosystems presentationEcosystems presentation
Ecosystems presentationforagroup
 
Responsible investment & governance annual report 2011
Responsible investment & governance annual report 2011Responsible investment & governance annual report 2011
Responsible investment & governance annual report 2011Nordea Bank
 
Cloud on PureSystems, Botond Kiss
Cloud on PureSystems, Botond KissCloud on PureSystems, Botond Kiss
Cloud on PureSystems, Botond KissIBMSERBIA
 
Proposed FY2012 Commonwealth Budget :: ANALYSIS
Proposed FY2012 Commonwealth Budget :: ANALYSISProposed FY2012 Commonwealth Budget :: ANALYSIS
Proposed FY2012 Commonwealth Budget :: ANALYSISuwlackawayne
 
States of Fragility report
States of Fragility reportStates of Fragility report
States of Fragility reportAlison Burt
 
Nets_annual report_2015_FINAL
Nets_annual report_2015_FINALNets_annual report_2015_FINAL
Nets_annual report_2015_FINALKlaus Madsen
 
Lead With Intent on Linked In
Lead With Intent on Linked InLead With Intent on Linked In
Lead With Intent on Linked Inpeders
 
Rethinking wicked problems
Rethinking wicked problemsRethinking wicked problems
Rethinking wicked problemsLeif Rasmussen
 

Viewers also liked (20)

Aarbog 09 1979_forsknings_og_litteraturoversigt
Aarbog 09 1979_forsknings_og_litteraturoversigtAarbog 09 1979_forsknings_og_litteraturoversigt
Aarbog 09 1979_forsknings_og_litteraturoversigt
 
ABC Breakfast Club m. Abena: 40% færre restordre
ABC Breakfast Club m. Abena: 40% færre restordreABC Breakfast Club m. Abena: 40% færre restordre
ABC Breakfast Club m. Abena: 40% færre restordre
 
You gov bankundersøgelse_finansagenda2014_final
You gov bankundersøgelse_finansagenda2014_finalYou gov bankundersøgelse_finansagenda2014_final
You gov bankundersøgelse_finansagenda2014_final
 
Community development and networks
Community development and networksCommunity development and networks
Community development and networks
 
Programma di sala novembre 2011
Programma di sala novembre 2011Programma di sala novembre 2011
Programma di sala novembre 2011
 
Time Management Energistyrelsen
Time Management EnergistyrelsenTime Management Energistyrelsen
Time Management Energistyrelsen
 
Ecosystems presentation
Ecosystems presentationEcosystems presentation
Ecosystems presentation
 
Responsible investment & governance annual report 2011
Responsible investment & governance annual report 2011Responsible investment & governance annual report 2011
Responsible investment & governance annual report 2011
 
Cloud on PureSystems, Botond Kiss
Cloud on PureSystems, Botond KissCloud on PureSystems, Botond Kiss
Cloud on PureSystems, Botond Kiss
 
Proposed FY2012 Commonwealth Budget :: ANALYSIS
Proposed FY2012 Commonwealth Budget :: ANALYSISProposed FY2012 Commonwealth Budget :: ANALYSIS
Proposed FY2012 Commonwealth Budget :: ANALYSIS
 
Anesthesia Business Consultants: Communique spring12
Anesthesia Business Consultants: Communique spring12Anesthesia Business Consultants: Communique spring12
Anesthesia Business Consultants: Communique spring12
 
States of Fragility report
States of Fragility reportStates of Fragility report
States of Fragility report
 
Dedication clemmensen
Dedication clemmensenDedication clemmensen
Dedication clemmensen
 
MMV Annual_Report_2015, My Interview
MMV Annual_Report_2015, My InterviewMMV Annual_Report_2015, My Interview
MMV Annual_Report_2015, My Interview
 
Nets_annual report_2015_FINAL
Nets_annual report_2015_FINALNets_annual report_2015_FINAL
Nets_annual report_2015_FINAL
 
Lead With Intent on Linked In
Lead With Intent on Linked InLead With Intent on Linked In
Lead With Intent on Linked In
 
Rethinking wicked problems
Rethinking wicked problemsRethinking wicked problems
Rethinking wicked problems
 
TEX07AR
TEX07ARTEX07AR
TEX07AR
 
Book In English
Book In EnglishBook In English
Book In English
 
Pharma Market 45
Pharma Market 45Pharma Market 45
Pharma Market 45
 

Similar to Behandling av undernäring ger bättre kliniskt förlopp

091110 Kondrup IHF Rio
091110 Kondrup IHF Rio091110 Kondrup IHF Rio
091110 Kondrup IHF RioJens Kondrup
 
Analyses of Risk Factors of Diarrhea in Patients with Esophagectomy
Analyses of Risk Factors of Diarrhea in Patients with EsophagectomyAnalyses of Risk Factors of Diarrhea in Patients with Esophagectomy
Analyses of Risk Factors of Diarrhea in Patients with Esophagectomysemualkaira
 
Integrating icosapent ethyl in clinical practice: which patients will benefits?
Integrating icosapent ethyl in clinical practice: which patients will benefits?Integrating icosapent ethyl in clinical practice: which patients will benefits?
Integrating icosapent ethyl in clinical practice: which patients will benefits?Sociedad Española de Cardiología
 
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)European School of Oncology
 
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)European School of Oncology
 
EUS Guided Anti Tumor Therapyversion0
EUS Guided Anti Tumor Therapyversion0EUS Guided Anti Tumor Therapyversion0
EUS Guided Anti Tumor Therapyversion0Shivakumar Vignesh
 
MCO 2011 - Slide 11 - M. Aapro - Antiemetics, growth factors, bone health
MCO 2011 - Slide 11 - M. Aapro - Antiemetics, growth factors, bone healthMCO 2011 - Slide 11 - M. Aapro - Antiemetics, growth factors, bone health
MCO 2011 - Slide 11 - M. Aapro - Antiemetics, growth factors, bone healthEuropean School of Oncology
 
MON 2011 - Slide 9 - M. Aapro - Antiemetics, growth factors, bone health
MON 2011 - Slide 9 - M. Aapro - Antiemetics, growth factors, bone healthMON 2011 - Slide 9 - M. Aapro - Antiemetics, growth factors, bone health
MON 2011 - Slide 9 - M. Aapro - Antiemetics, growth factors, bone healthEuropean School of Oncology
 
Rare Solid Cancers: An Introduction - Slide 14 - E. Baudin - Neuroendocrine t...
Rare Solid Cancers: An Introduction - Slide 14 - E. Baudin - Neuroendocrine t...Rare Solid Cancers: An Introduction - Slide 14 - E. Baudin - Neuroendocrine t...
Rare Solid Cancers: An Introduction - Slide 14 - E. Baudin - Neuroendocrine t...European School of Oncology
 
VTE and Cancer Healthcare Professional Education
VTE and Cancer Healthcare Professional EducationVTE and Cancer Healthcare Professional Education
VTE and Cancer Healthcare Professional Educationvtesimplified
 
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.Max Peters
 
Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...
Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...
Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...SMACC Conference
 
Endometrial Carcinoma.Adjuvant Treatment
Endometrial Carcinoma.Adjuvant TreatmentEndometrial Carcinoma.Adjuvant Treatment
Endometrial Carcinoma.Adjuvant Treatmentbalaganoff
 
Breast cancer a focus on bone health integrity
Breast cancer  a focus on bone health integrityBreast cancer  a focus on bone health integrity
Breast cancer a focus on bone health integrityMohamed Abdulla
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
Management of Gastric Cancer in 2017
Management of Gastric Cancer in 2017Management of Gastric Cancer in 2017
Management of Gastric Cancer in 2017Mohamed Abdulla
 
inflammatory_bowel_disease.ppt
inflammatory_bowel_disease.pptinflammatory_bowel_disease.ppt
inflammatory_bowel_disease.pptNandishKumar29
 

Similar to Behandling av undernäring ger bättre kliniskt förlopp (20)

091110 Kondrup IHF Rio
091110 Kondrup IHF Rio091110 Kondrup IHF Rio
091110 Kondrup IHF Rio
 
Oesophageal cancer osama
Oesophageal cancer osamaOesophageal cancer osama
Oesophageal cancer osama
 
Analyses of Risk Factors of Diarrhea in Patients with Esophagectomy
Analyses of Risk Factors of Diarrhea in Patients with EsophagectomyAnalyses of Risk Factors of Diarrhea in Patients with Esophagectomy
Analyses of Risk Factors of Diarrhea in Patients with Esophagectomy
 
Dugo Iasgo 09
Dugo Iasgo 09Dugo Iasgo 09
Dugo Iasgo 09
 
Integrating icosapent ethyl in clinical practice: which patients will benefits?
Integrating icosapent ethyl in clinical practice: which patients will benefits?Integrating icosapent ethyl in clinical practice: which patients will benefits?
Integrating icosapent ethyl in clinical practice: which patients will benefits?
 
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
 
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
 
EUS Guided Anti Tumor Therapyversion0
EUS Guided Anti Tumor Therapyversion0EUS Guided Anti Tumor Therapyversion0
EUS Guided Anti Tumor Therapyversion0
 
MCO 2011 - Slide 11 - M. Aapro - Antiemetics, growth factors, bone health
MCO 2011 - Slide 11 - M. Aapro - Antiemetics, growth factors, bone healthMCO 2011 - Slide 11 - M. Aapro - Antiemetics, growth factors, bone health
MCO 2011 - Slide 11 - M. Aapro - Antiemetics, growth factors, bone health
 
MON 2011 - Slide 9 - M. Aapro - Antiemetics, growth factors, bone health
MON 2011 - Slide 9 - M. Aapro - Antiemetics, growth factors, bone healthMON 2011 - Slide 9 - M. Aapro - Antiemetics, growth factors, bone health
MON 2011 - Slide 9 - M. Aapro - Antiemetics, growth factors, bone health
 
Rare Solid Cancers: An Introduction - Slide 14 - E. Baudin - Neuroendocrine t...
Rare Solid Cancers: An Introduction - Slide 14 - E. Baudin - Neuroendocrine t...Rare Solid Cancers: An Introduction - Slide 14 - E. Baudin - Neuroendocrine t...
Rare Solid Cancers: An Introduction - Slide 14 - E. Baudin - Neuroendocrine t...
 
VTE and Cancer Healthcare Professional Education
VTE and Cancer Healthcare Professional EducationVTE and Cancer Healthcare Professional Education
VTE and Cancer Healthcare Professional Education
 
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
 
Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...
Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...
Oesophageal surgery- Is there light at the end of the tunnel? Professor Neil ...
 
Endometrial Carcinoma.Adjuvant Treatment
Endometrial Carcinoma.Adjuvant TreatmentEndometrial Carcinoma.Adjuvant Treatment
Endometrial Carcinoma.Adjuvant Treatment
 
7 capdevila
7 capdevila7 capdevila
7 capdevila
 
Breast cancer a focus on bone health integrity
Breast cancer  a focus on bone health integrityBreast cancer  a focus on bone health integrity
Breast cancer a focus on bone health integrity
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
Management of Gastric Cancer in 2017
Management of Gastric Cancer in 2017Management of Gastric Cancer in 2017
Management of Gastric Cancer in 2017
 
inflammatory_bowel_disease.ppt
inflammatory_bowel_disease.pptinflammatory_bowel_disease.ppt
inflammatory_bowel_disease.ppt
 

Recently uploaded

College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...narwatsonia7
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalorenarwatsonia7
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Deliverynehamumbai
 
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowSonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowRiya Pathan
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escortsaditipandeya
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatorenarwatsonia7
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...Miss joya
 
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...narwatsonia7
 
Call Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
Call Girls Chennai Megha 9907093804 Independent Call Girls Service ChennaiCall Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
Call Girls Chennai Megha 9907093804 Independent Call Girls Service ChennaiNehru place Escorts
 
Low Rate Call Girls Ambattur Anika 8250192130 Independent Escort Service Amba...
Low Rate Call Girls Ambattur Anika 8250192130 Independent Escort Service Amba...Low Rate Call Girls Ambattur Anika 8250192130 Independent Escort Service Amba...
Low Rate Call Girls Ambattur Anika 8250192130 Independent Escort Service Amba...narwatsonia7
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safenarwatsonia7
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...narwatsonia7
 

Recently uploaded (20)

College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
 
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
VIP Call Girls Tirunelveli Aaradhya 8250192130 Independent Escort Service Tir...
 
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Marathahalli 📞 9907093804 High Profile Service 100% Safe
 
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Nandini 7001305949 Independent Escort Service Bangalore
 
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on DeliveryCall Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
Call Girls Colaba Mumbai ❤️ 9920874524 👈 Cash on Delivery
 
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowSonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
 
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore EscortsVIP Call Girls Indore Kirti 💚😋  9256729539 🚀 Indore Escorts
VIP Call Girls Indore Kirti 💚😋 9256729539 🚀 Indore Escorts
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
 
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
 
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
 
Call Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
Call Girls Chennai Megha 9907093804 Independent Call Girls Service ChennaiCall Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
Call Girls Chennai Megha 9907093804 Independent Call Girls Service Chennai
 
Low Rate Call Girls Ambattur Anika 8250192130 Independent Escort Service Amba...
Low Rate Call Girls Ambattur Anika 8250192130 Independent Escort Service Amba...Low Rate Call Girls Ambattur Anika 8250192130 Independent Escort Service Amba...
Low Rate Call Girls Ambattur Anika 8250192130 Independent Escort Service Amba...
 
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% SafeBangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
Bangalore Call Girls Majestic 📞 9907093804 High Profile Service 100% Safe
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
 

Behandling av undernäring ger bättre kliniskt förlopp

  • 1.
  • 2. loBMI Stratton RJ, Green CJ, Elia M. Disease-related malnutrition. CABI Publishing 2003
  • 5. Prevalence of undernutrition Stratton RJ, Green CJ, Elia M. Disease-related malnutrition CABI Publishing 2003 10 30 % of these undernourished 995 150 Prevalence (per 100.000) 10 100 % of these diseased 99.5 0.5 % of population Community Hospital
  • 6. Europe 1 OOPS! 26 departments from 12 countries Interested, but limited experience with nutrition support. Sponsored by Fresenius-Kabi. 49 560 216 306 48 22 296 59 131 83 88 187 856 388 479 21 182 50 52 68 273 276 151 162 207 60
  • 7. % at risk according to NRS-2002 Sorensen et al. Clin Nutr 2008; 27: 340-9 32 543 Gastroenterology 94 309 ICU 28 338 Oncology 5051 209 1783 1715 N 33 52 33 19 % At-risk Total Geriatrics Internal medicine Surgery
  • 8. Complications Sorensen et al. Clin Nutr 2008; 27: 340-9 100 (1647) 14 (234) 16 (270) 69 (1143) At-risk * P<0.001 100 (3404) 5 (165) 6 (218) 89 (3021) Not at-risk Total Infectious Complication Non-infectious Complication No Complication   At risk according to NRS-2002 Percent of patients with non-infectious or infectious complications (N) Cancer Age Region (Western Europe, Eastern Europe, Middle East) Speciality (geriatry, gastroenterology, oncology, internal medicine, surgical, ICU) Diagnoses (19 most frequent) Comorbidity Surgery Complications were independenly associated with NRS-2002 components (nutritional status and severity of disease), also when adjusted for:
  • 9. Type of complications Sorensen et al. EuroOOPS: an international, multicentre study of nutritional risk screening and clinical outcome in 5.000 patients. Clin Nutr 27 340-9, 2008 Primary disease determines the type of complication - malnutrition makes it happen
  • 10. LOS, all Sorensen et al. Clin Nutr 2008; 27: 340-9
  • 11. Length of stay Sorensen et al. Clin Nutr 2008; 27: 340-9 12.9  0.4 (189) 11.2  0.4 (219) 8.9  0.2 (1055) At-risk Not At-risk No Complication versus all other groups: P<0.0001 for each 11.0  0.5 (127) 10.9  0.4 (199) 6.9  0.1 (2881) Not at-risk Infectious Complication Total Non-infectious Complication No Complication   At risk according to NRS-2002: LOS (mean  SEM) in different categories (N) Cancer Age Region (Western Europe, Eastern Europe, Middle East) Death. Speciality (geriatry, gastroenterology, oncology, internal medicine, surgical, ICU) Diagnoses (19 most frequent) Comorbidity Surgery LOS was independenly associated with NRS-2002 components (nutritional status and severity of disease), also when adjusted for:
  • 12. Length of stay; survival Sorensen et al. Clin Nutr 2008; 27: 340-9
  • 13. Odds for discharge < 28 days Sorensen et al. Clin Nutr 2008; 27: 340-9 Cox regression analysis N = 5046; LOS  28 (N=379) are right censored <0.0001 0.78 Co-morbidity <0.0001 0.55 Complication <0.0001 0.74 Cancer 0.008 1.09 Surgery 0.003 1.09 Sex, male versus female <0.0001 0.76 At-risk P OR
  • 14. Prevalence of malnutrition in Denmark 36 Orthoped surgery (249) 57 Gastro surgery (148) 42 Internal medicine (238) % at-risk NRS-2002 Speciality (N) A random selection of 5 departments for each of 3 specialities: internal medicine, gastro-surgery and orthopedic surgery in hospitals >200 beds. Result:15 departments in 12 out of 33 hospitals. Rasmussen et al. Clin Nutr 2004;23:1009-15 .
  • 15. Prevalence: Care 14 (33:8) 1) Plan (req, food type, monitor) 1) Related to recent weight loss and severity of disease, but not to BMI or recent intake 20 (33:10) Recent dietary intake 12 (19:7) Recent weight loss 64 (similar) Weight % (at-risk:not at risk) Information in records Nutritional care Rasmussen et al. Clin Nutr 2004;23:1009-15.
  • 16.
  • 17. Evidence is here! Meta-analysis of a large number of trials shows that nutritional support improves clinical outcome Stratton RJ, Green CJ, Elia M. Disease-related malnutrition: an evidence-based approach. CABI Publishing 2003
  • 18. RCT: Complications % mortality Stratton RJ, Green CJ, Elia M. Disease-related malnutrition. CABI Publishing 2003 24% vs. 44% 1) Infections 2) 17 % vs. 24% 1) Mortality 1) P <0.001; 2) 10 RCTs only Meta-analysis of 27 RCTs with 1710 patients (complications) and 30 RCTs with 3250 patients (mortality). Neurology, GI disease, liver disease, malignant disease, elderly, abdominal surgery, orthopaedic surgery, critical illness/injury, burns. Hospital or community Oral supplements or tube feeding 28% vs. 46% 1) Complications
  • 19. Meta-analysis: Surgery Stratton RJ, Green CJ, Elia M. Disease-related malnutrition 2003
  • 20. Meta-analysis: Internal medicin Stratton RJ, Green CJ, Elia M. Disease-related malnutrition 2003
  • 21. Clinical effect: Gastro-intestinal surgery References in Kondrup et al. Clin Nutr 2003; 22: 321-336 infection/ON (82) infection/ON (79) infection/EN (20) infection/EN (37) infection/EN (83) infection/EN (84) infection/PN (1) infection/PN (19) infection/PN (38) infection/PN/EN (80) infection/PN (123) complications/ PN (77) complications/PN (78) complications/PN (87) complications/PN (124) LOS/EN (86) LOS/PN (21) survival/PN (43) survival/PN (125)
  • 22. Clinical effect: References in Kondrup et al. Clin Nutr 2003; 22: 321-336 tolerance/ON (2) tolerance/PN (39) tolerance/PN (40) tolerance/ON (41) QoL/EN (35) survival/PN (44) survival/PN (91) Cancer Clin Index/PN (36) encephalopathy/EN (42) infection/EN (81) LOS/PN (88) survival/ON (93) Cirrhosis LOS/ON (3) LOS/ON (4) survival/EN (5) Femoral fracture infection/EN (18) LOS/EN (29) survival/PN (30) Trauma ADL/ON (34) ADL/ON (85) survival/ON (45) Geriatry survival/PN (89) survival/PN (90) Acute Renal Failure infection/burns/EN (28) survival/BMT/PN (31) survival/stroke/ON (92) Misc.
  • 23.
  • 24. Impact of malnutrition on healthcare costs The pooled results from the analysis of all the hospital-based studies indicated a mean net cost saving from the use of oral nutritional supplements of £849 per patient based on bed-day costs and £298 per patient using complication costs. Russell C, Clinical Nutrition Supplements 2007; 2: 25–32 Elia M, Stratton RJ, Russell C, Green CJ, Pang F. The Cost of disease–related malnutrition in the UK. BAPEN 2005 The total direct costs of disease-related malnutrition represent approximately 10% of the total expenditure on health in the UK. 7.3 £ million is two fold greater than the reported costs of managing obesity and its consequences in the UK
  • 25. UK Costs applied to Euro-OOPS. LOS + Complications Calculated from Cost of LOS (£ 258/day) + Cost of Complication (£ 1500) with extra LOS subtracted ((LOS compl-LOS no compl) x £ 258) Based on Elia M, Stratton RJ, Russell C, Green CJ, Pang F. The Cost of disease–related malnutrition in the UK. BAPEN 2005 1.6 0.3 1.3 408 Mal, compl 2.4 0.9 5.1 10 6 £ LOS 0.2 10 6 £ Compl >  LOS 1055 326 2881 N Total Mal, no compl Well, compl Well, no compl Group 5.1 10.2 2.4 1.1 10 6 £ Total
  • 26. UK Costs applied to Euro-OOPS. Additional cost of malnutrition: (Cost of mal) – (# of mal x cost of average well  complications, £ 1929) Based on Elia M, Stratton RJ, Russell C, Green CJ, Pang F. The Cost of disease–related malnutrition in the UK. BAPEN 2005 11% Mal in % of total (1.1 x 100/10.2) 10.2 Total, £ million (2.4 +1.6) – (1,463 x 1,929) = 1.1 £ million
  • 27. UK Costs applied to Euro-OOPS. Additional cost of treated malnutrition: (Cost of mal) – (# of mal x cost of average well  complications, £ 1929) Elia M, Stratton RJ, Russell C, Green CJ, Pang F.The Cost of disease–related malnutrition in the UK. BAPEN 2005 0.7 Cost of treated mal (0.4 + 0.3), £ million 0.3 Cost of treatment (# mal x LOS x £ 24.6), £ million 6% Treated mal, % of total (0.7 x 100/10.2) 10.2 Total, £ million (2.4 +0.7) – (1,463 x 1,929) = 0.4 £ million versus 1.1 in untreated
  • 28. Results applied to DK health care (in £) 140 £ million = 1.3 milliarder DKK 140 Saving, £ million 7. 287 Mal, 11% of 2., £ million 5. 146 Treated mal, 6% of 2., £ million 6. 8. 4. 3. 2. 1. 5,442 Total costs for in-patients, £ million 6.0 Saving, % of Total DRG (=7./2.) 392 Av bed day cost DRG, £ (= 2./3.) 6.5 Bed days per year, million 2,547 Total DRG costs, £ million Item
  • 29.
  • 30.
  • 31.
  • 32.
  • 33. Appendix: The level of government/health authority Editorial Clin Nutr 2004; 23:135-137 These key recommendations will help the level of government/health authority to: 1) evaluate the adequacy of nutrition activities in individual hospitals 2) evaluate unfortunate individual cases.
  • 34.
  • 35.
  • 36. EU… Europaparlamentet vedtog den 25. September 2008 ændringer til EU kommissionens ’White paper on nutrition, overweight and obesity-related health issues’ fra Juni 2007 Malnutrition is a heavy burden both for individual wellbeing and for society, particularly the health care system, and it results in increased mortality, longer hospital stays, greater complications and reduced quality of life for patients; extra days in hospital and treatment of complications due to malnutrition cost billions of euros in public funding every year. Urges the Commission to take a more holistic approach to nutrition and make malnutrition, alongside obesity, a key priority in the fields of nutrition and health, incorporating it wherever possible into EU-funded research initiatives and EU-level partnerships.
  • 37.
  • 38.
  • 39. Institut for Kvalitet og Akkreditering i Sundhedsvæsenet www.kvalitetsinstitut.dk
  • 40.
  • 41.
  • 42.
  • 43.
  • 44. Key question: Nutritional support was effective in the RCTs – but how were the patients actually selected? Do the patients selected for these studies have a common denominator for risk of nutrition-related complications (= nutritional risk) ? To implement the evidence: develop a screening tool based on evidence that outcome will change, i.e. the available RCTs Other specialities? Fraction of patients  etc Speciality 4 Speciality 3 Speciality 2 Speciality 1
  • 45.  
  • 46. Concept Nutritional risk = risk of complications due to nutritional impairment
  • 47. Components in Screening by NRS-2002 – ESPEN guideline Impaired nutritional status BMI (  present condition) Recent weight loss (  past tendency) Recent dietary intake (  future tendency) Nutritional requirements  Severity of disease  E.g. protein requirements in various disease states (stress metabolism) www.espen.org  education; Kondrup et al. Clin Nutr 2003; 22: 321-336 + 415-421
  • 48. NRS-2002 _DK www.espen.org  education; Kondrup et al. Clin Nutr 2003; 22: 321-336 + 415-421 Hvis alder  70: læg 1 til Total. Ved Total  3: start ernæringsterapi Score = Total: Score + Kranietraumer, forbrænding > 50% S være infektioner (sepsis), intensiv ptt . Svær = 3 Vægttab > 5% på 1 måned/15% på 3 måneder 1 eller BMI  18,5 og påvirket almentilstand eller Kostindtagelse 0-25%  1 uge Svær = 3 Store abdominalkirurgiske indgreb (colektomi, gastrektomi, hepatektomi) Postoperativ ATIN, apopleksi Svær pneumoni Moderat = 2 Vægttab > 5% på 1 1/2 måned eller BMI 18,5-20,5 og påvirket almentilstand eller Kostindtagelse 25-50%  1 uge Moderat = 2 Collum femoris fraktur Kronisk prægede ptt., særligt ved akutte komplikationer: levercirrhose, KOL Kronisk prægede ptt. med nyreinsufficiens, IDDM eller cancer Let = 1 Vægttab > 5% på 3 måneder eller Kostindtagelse 50-75%  1 uge Let = 1 Sværhedsgrad af sygdom Underernæring
  • 49. all
  • 50. ON Kondrup et al. Clin Nutr 2003; 22: 321-336
  • 51. EN Kondrup et al. Clin Nutr 2003; 22: 321-336
  • 52. PN Kondrup et al. Clin Nutr 2003; 22: 321-336
  • 53.
  • 54. Intake UPS  This is the solution 
  • 55. RCT with 212 at-risk patients (NRS-2002) randomized to departments’ routine or daily follow-up by team of nurse and dietitian. Length of Stay Johansen N et al. Clin Nutr 2004; 23:539-550 1) Team versus Control: P = 0.028; ANOVA 17  2 1) 18 22  2 14 Complications 9  1 50 9  1 69 No complications Mean  SEM N Mean  SEM N Team Control
  • 56.
  • 57. ESPEN guideline: screening linked to action ESPEN Guidelines for Nutrition Screening 2002. Clin Nutr 2003;22(4):415-421. 1. Screening 2. Nutrition Plan 3. Monitoring 4. Communication 5. Audit
  • 58. Nutrition treatment: a structured process ESPEN Guidelines for Nutrition Screening 2002. Clin Nutr 2003;22(4):415-421.
  • 59. Context of the structured process Kondrup Clin Nutr 2001; 20(suppl 2): 153-160, b ased on BAPEN report 1999: Hospital Food as Treatment
  • 60. Copenhagen audit March 2006 Accreditation 2002 & 2005
  • 61. Reliability of audit results in Copenhagen 480 patients in 24 departments in 5 hospitals Holm et al. ESPEN Congress 2006: Abstract # P 0281 91% 3) 74% 106/143 Dietary recording Correct, % Done, % n/N Activity Most frequent causes of errors: 1) Undiscovered weight loss 2) Undiscovered weight loss/wrong category of severity of disease 3) Erroneus calculation of requirements 89% 2) 98% 220/224 Final screening 85% 1) 78% 374/480 Initial screening
  • 62. Causes of inadequate intake 111 of 246 at-risk patients had an intake <75% of requirement. The nurses gave max 1 answer in each of 5 categories: Patient, Nurse, Food, System, Other. An average of 3 reasons per patient. 83 different combinations. 74 patients had an individual combination. The combinations shared by  3 patients are shown here. Holm et al. ESPEN Congress 2006: Abstract # P 0281
  • 63.